Information
C4U Selected for the AMED “Project to Promote the Industrialization of Regenerative/CellMedicine and Gene Therapy”
C4U announces that our ongoing research and development of the gene and cell therapy utilizing CRISPR-Cas3 technology has been selected as a research project supported by AMED (Japan Agency for Medical Research and Development) for the fiscal year 2024 “Development of Basic Technologies for Industrialization of Regenerative Medicine and Gene Therapy (Project to Promote the Industrialization of Regenerative/Cell Medicine and Gene Therapy) (Development Support Project)”.